LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Helium-Free, Bench-Top MRI Scanner Draws Interest at Meetings

By LabMedica International staff writers
Posted on 21 May 2013
Print article
Ultra-compact, helium-free, preclinical, bench-top magnetic resonance imaging (MRI) scanners have been designed for preclinical imaging of lab animals.

The MR Solutions presented the new scanner at the American Association for Cancer Research (AACR) annual meeting in Washington DC (USA), on April 6-10, 2013, and the International Society for Magnetic Resonance in Medicine (ISMRM) annual meeting in Salt Lake City (UT, USA), on April 20-26, 2013. The new technology spurred a lot of interest for the participants.

Dr. David Taylor, CEO of MR Solutions (Guildford, UK), said, “We were overwhelmed by the interest in this new scanner one of a range to follow soon. We were repeatedly told it was a game changer; producing high quality images without compromise and able to fit within an existing laboratory at a price which is more than competitive.”

MR Solutions, developed the world’s first commercial 3T scanner late in 2012, and in January 2013, introduced two larger bore machines to complete the range. The smaller two of the new scanners, the 16-cm bore, is available now (3T) while the other two machines—31-cm 3T and 72-cm 1.5T—will be available by the end of 2013; orders for these units are already in the works. The new range of three scanners will be able to scan from small to medium-sized animals.

The advantages of these technologic advances are: (1) the scanners provide excellent soft tissue contrast and molecular imaging capabilities. (2) They are very cost-effective as there is no need for all the cryogen cooling equipment. (3) Because they have a very small stray magnetic field, the scanners can be positioned close to other imaging equipment to enable multimodality imaging on the same subject. (4) Lastly, because of the lack of liquid helium cooling and required safety equipment, the scanners are easy to install and need no expensive building alterations.

Related Links:

MR Solutions


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more